nach oben

Erschienen in:

01.12.2009 | Article

Coffee and tea consumption and risk of type 2 diabetes

verfasst von: S. van Dieren, C. S. P. M. Uiterwaal, Y. T. van der Schouw, D. L. van der A, J. M. A. Boer, A. Spijkerman, D. E. Grobbee, J. W. J. Beulens

Erschienen in: Diabetologia | Ausgabe 12/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The aim of this study was to examine the association of consumption of coffee and tea, separately and in total, with risk of type 2 diabetes and which factors mediate these relations.

Methods

This research was conducted as part of the Dutch Contribution to the European Prospective Investigation into Cancer and Nutrition, which involves a prospective cohort of 40,011 participants with a mean follow-up of 10 years. A validated food-frequency questionnaire was used to assess coffee and tea consumption and other lifestyle and dietary factors. The main outcome was verified incidence of type 2 diabetes. Blood pressure, caffeine, magnesium and potassium were examined as possible mediating factors.

Results

During follow-up, 918 incident cases of type 2 diabetes were documented. After adjustment for potential confounders, coffee and tea consumption were both inversely associated with type 2 diabetes, with hazard ratios of 0.77 (95% CI 0.63–0.95) for 4.1–6.0 cups of coffee per day (p for trend = 0.033) and 0.63 (95% CI: 0.47–0.86) for >5.0 cups of tea per day (p for trend = 0.002). Total daily consumption of at least three cups of coffee and/or tea reduced the risk of type 2 diabetes by approximately 42%. Adjusting for blood pressure, magnesium, potassium and caffeine did not attenuate the associations.

Conclusions/interpretation

Drinking coffee or tea is associated with a lowered risk of type 2 diabetes, which cannot be explained by magnesium, potassium, caffeine or blood pressure effects. Total consumption of at least three cups of coffee or tea per day may lower the risk of type 2 diabetes.

Wild S, Roglic G, Green A, Sicree R, King H (2004) Global Prevalence of Diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed

Hu FB, Manson JE, Stampfer MJ et al (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797CrossRefPubMed

Lindström J, Ilanne-Parikka P, Peltonen M et al (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368:1673–1679CrossRefPubMed

Van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. J Am Med Assoc 294:97–104CrossRef

Hamer M, Witte DR, Mosdol A, Marmot MG, Brunner EJ (2008) Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: The Whitehall II study. Br J Nutr 1046–1053

Iso H, Date C, Wakai K et al (2006) The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 144:554–562PubMed

Barbagallo M, Dominguez LJ (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 458:40–47CrossRefPubMed

Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE (1992) Diet and risk of clinical diabetes in women. Am J Clin Nutr 55:1018–1023PubMed

Park S, Jang JS, Hong SM (2007) Long-term consumption of caffeine improves glucose homeostasis by enhancing insulinotropic action through islet insulin/insulin-like growth factor 1 signaling in diabetic rats. Metabolism 56:599–607CrossRefPubMed

10.

Keijzers GB, de Galan BE, Tack CJ, Smits P (2002) Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25:364–369CrossRefPubMed

11.

Lane JD, Barkauskas CE, Surwit RS, Feinglos MN (2004) Caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 27:2047–2048CrossRefPubMed

12.

Uiterwaal CSPM, Verschuren WMM, Bueno-de-Mesquita HB et al (2007) Coffee intake and incidence of hypertension. Am J Clin Nutr 85:718–723PubMed

13.

Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC (2005) Habitual caffeine intake and the risk of hypertension in women. J Am Med Assoc 294:2330–2335CrossRef

14.

Stolk RP, van Splunder IP, Schouten JS, Witteman JC, Hofman A, Grobbee DE (1993) High blood pressure and the incidence of non-insulin dependent diabetes mellitus: findings in a 11.5 year follow-up study in The Netherlands. Eur J Epidemiol 9:134–139CrossRefPubMed

15.

Meisinger C, Doring A, Heier M (2008) Blood pressure and risk of type 2 diabetes mellitus in men and women from the general population: the Monitoring Trends and Determinants on Cardiovascular Diseases/Cooperative Health Research in the Region of Augsburg Cohort Study. J Hypertens 26:1809–1815CrossRefPubMed

16.

Baron AD, Brechtel-Hook G, Johnson A, Hardin D (1993) Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 21:129–135PubMed

17.

Riboli E, Kaaks R (1997) The EPIC Project: rationale and study design. Int J Epidemiol 26:S6–S14CrossRefPubMed

18.

Beulens JW, Monninkhof EM, Verschuren MW et al (2009) Cohort profile: The EPIC-NL study. Int J Epidemiol doi:10.1093/ije/dyp217

19.

Schulze MB, Kroke A, Saracci R, Boeing H (2002) The effect of differences in measurement procedure on the comparability of blood pressure estimates in multi-centre studies. Blood Press Monit 7:95–104CrossRefPubMed

20.

Ocké MC, Bueno-de-Mesquita HB, Goddijn HE et al (1997) The Dutch EPIC Food Frequency Questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol 26:S37–S48CrossRefPubMed

21.

Ocké MC, Bueno-de-Mesquita HB, Pols MA, Smit HA, van Staveren WA, Kromhout D (1997) The Dutch EPIC Food Frequency Questionnaire. II. Relative validity and reproducibility for nutrients. Int J Epidemiol 26:S49–S58CrossRefPubMed

22.

Beulens JWJ, Stolk RP, van Der Schouw YT, Grobbee DE, Hendriks HFJ, Bots ML (2005) Alcohol consumption and risk of type 2 diabetes among older women. Diabetes Care 28:2933–2938CrossRefPubMed

23.

ICDData.com. ICD-9-CM Diagnosis 250. Available from www.icd9data.com/2007/Volume1/240-279/250-259/250/default.htm, accessed 18 August 2009

24.

Herings RMC, Bakker A, Stricker BHC, Nap G (1992) Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 46:136–140CrossRefPubMed

25.

Vereniging van nederlandse koffiebranders en theepakkers (2006) Jaarverslag 2006. Available from www.vnkt.nl/vnkt/pdf/VNKT%20Jaarverslag%202006.pdf, accessed 18 August 2009

26.

Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819CrossRefPubMed

27.

Salazar-Martinez E, Willett WC, Ascherio A et al (2004) Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140:1–8PubMed

28.

Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P (2004) Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. J Am Med Assoc 291:1213–1219CrossRef

29.

Van Dam RM, Willett WC, Manson JE, Hu FB (2006) Coffee, caffeine, and risk of type 2 diabetes: A prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 29:398–403CrossRefPubMed

30.

Pereira MA, Parker ED, Folsom AR (2006) Coffee consumption and risk of type 2 diabetes mellitus: An 11-year prospective study of 28 812 postmenopausal women. Arch Int Med 166:1311–1316CrossRef

31.

Ranheim T, Halvorsen B (2005) Coffee consumption and human health—beneficial or detrimental?—Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 49:274–284CrossRefPubMed

32.

Odegaard AO, Pereira MA, Koh WP, Arakawa K, Lee HP, Yu MC (2008) Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 88:979–985PubMed

33.

Jing Y, Han G, Hu Y, Bi Y, Li L, Zhu D (2009) Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies. J Gen Intern Med 24:557–562CrossRefPubMed

34.

Polychronopoulos E, Zeimbekis A, Kastorini CM et al (2008) Effects of black and green tea consumption on blood glucose levels in non-obese elderly men and women from Mediterranean Islands (MEDIS epidemiological study). Eur J Nutr 47:10–16CrossRefPubMed

35.

Greenberg JA, Axen KV, Schnoll R, Boozer CN (2005) Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes (Lond) 29:1121–1129CrossRef

36.

Van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR (2006) Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women. Diabetes Care 29:2238–2243CrossRefPubMed

37.

van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32:1023–1025CrossRefPubMed

38.

Song Y, Manson JE, Buring JE, Sesso HD, Liu S (2005) Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr 24:376–384PubMed

39.

Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52:1–8CrossRefPubMed

40.

Tunnicliffe JM, Shearer J (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 33:1290–1300CrossRefPubMed

41.

Montonen J, Knekt P, Rvinen R, Reunanen A (2004) Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 27:362–366CrossRefPubMed

42.

Liu S, Ajani U, Chae C, Hennekens C, Buring JE, Manson JE (1999) Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial. JAMA 282:1073–1075CrossRefPubMed

Titel: Coffee and tea consumption and risk of type 2 diabetes
verfasst von: S. van Dieren
C. S. P. M. Uiterwaal
Y. T. van der Schouw
D. L. van der A
J. M. A. Boer
A. Spijkerman
D. E. Grobbee
J. W. J. Beulens
Publikationsdatum: 01.12.2009
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 12/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-009-1516-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2009

Loss of islet sympathetic nerves and impairment of glucagon secretion in the NOD mouse: relationship to invasive insulitis

Regression of diabetic complications by islet transplantation in the rat

No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease

Neural crest stem cells increase beta cell proliferation and improve islet function in co-transplanted murine pancreatic islets

Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-β activity and TGF-β1 expression